SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

6:01AM Compugen announces results showing its CGEN-15001T drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 424
Posts 22,009
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/9/2016 7:11:29 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results "PR Newswire (US)" - 2/9/2016 7:09:00 AM
Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM EST "PR Newswire (US)" - 1/26/2016 7:00:00 AM
Compugen Achieves Third Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 12/11/2015 9:06:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/11/2015 8:31:41 AM
Compugen to Present at the Oppenheimer Healthcare Conference in New York "Business Wire" - 11/24/2015 7:00:00 AM
Compugen to Present at Jefferies 2015 Global Healthcare Conference in London "Business Wire" - 11/12/2015 7:00:00 AM
Compugen Presents Translational Study Results Supporting CGEN-15001 for the Treatment of Rheumatoid Arthritis "Business Wire" - 11/9/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/3/2015 8:02:40 AM
Compugen Ltd. Reports 3rd Quarter 2015 Financial Results "Business Wire" - 11/3/2015 7:00:00 AM
Compugen Third Quarter 2015 Conference Call Scheduled for Tuesday, November 3, 2015 at 10:00 AM ET "Business Wire" - 10/27/2015 7:52:00 AM
Compugen Discloses Antibody Drug Conjugate Program Results at the World ADC Summit in San Diego "Business Wire" - 10/19/2015 7:00:00 AM
Compugen Discloses New Results Supporting CGEN-15052 as Novel Immune Checkpoint Target Candidate for Treatment of Cancer "Business Wire" - 9/16/2015 7:00:00 AM
Compugen to Present at Upcoming Immuno-Oncology and Rheumatology Conferences "Business Wire" - 9/9/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/4/2015 7:17:55 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/4/2015 7:08:19 AM
Compugen Ltd. Reports 2nd Quarter 2015 Financial Results "Business Wire" - 8/4/2015 7:01:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/29/2015 10:57:07 AM
Compugen Second Quarter 2015 Conference Call Scheduled for Tuesday, August 4, 2015 at 10:00 AM ET "Business Wire" - 7/27/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/16/2015 11:16:46 AM
Compugen to Present at JMP Securities Life Sciences Conference in New York "Business Wire" - 6/15/2015 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/11/2015 9:09:05 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/8/2015 8:01:34 AM
Compugen to Disclose Novel Cancer Immunotherapy Target Candidate & Comprehensive Target Characterization Infrastructure at To... "Business Wire" - 6/8/2015 7:07:00 AM
Compugen to Present at Jefferies 2015 Global Healthcare Conference in New York "Business Wire" - 5/28/2015 7:00:00 AM
surf1944   Thursday, 02/02/12 10:57:15 AM
Re: surf1944 post# 109
Post # of 146 
6:01AM Compugen announces results showing its CGEN-15001T drug may have potential for cancer immunotherapy (CGEN) 5.30 : Co announced results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody ("mAb") therapy. These results indicate that CGEN-15001T is expressed on numerous types of cancer, such as carcinomas, sarcomas, melanoma and hematological cancers as well as on immune cells. These findings, together with previous results supporting its active immunomodulatory effect, 'strongly support CGEN-15001T's potential as a powerful drug target for treatment of various solid and hematological cancers, an area of great interest to the pharmaceutical industry.'


surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist